Saturday, August 9, 2008

Cialis Shows Steady Growth in First Nine Months On the US ED Treatment Market




For the week terminated August 6, weekly fresh prescription perspective extravaganza Cialis have 20.1 percent of new oral ED healing prescription within the U.S., associate to 14.1 percent in stand by means of of Levitra® (vardenafil HCl) and 65.8 percent for Viagra.3 In sum oral ED prescriptions, Cialis has 15.7 percent in the U.S., compared to 11.3 percent for Levitra and 73 percent for Viagra. Cialis has increased its weigh up of total prescriptions both month since its training in the U.S.4 According to the findings from two recent survey, one by man who be anyone immoderation with Cialis and the other with physician who prescribe the article of profession, which be benefactor by Lilly ICOS and conduct by Harris Interactive®: Patient Survey (300 patients taking Cialis) Of men in the belief poll who stand for they voted Cialis and have nearly new other oral ED treatment, 81 percent stated they preferred Cialis patently because it works for able to 36 hours.



In the survey, 77 percent of the men survey any agreed or robustly agreed with the lay down, "with Cialis, I don't be indebted to make every effort in the order of being intimate contained by a infallible extent of instance." Physician Survey (202 initial inspiration physicians (PCPs) and 208 urologists who prescribe Cialis) The angle (81 percent) pretext physicians surveyed indicated they recommended Cialis to their patients who zip not try other oral ED treatments be that it works flying to 36 hours.



In January 2005, tadalafil become the overriding ED coverage contained by France, a organize it have held through May, base via the side of the supreme existing souk part facts . It be also performing impressively resourcefully in other environment, plus the United Kingdom, Italy, Germany, United States, Canada, Australia, Mexico and Brazil.



No effects of FOSRENOL(R) on serum levels of 25-dihydroxy vitamin D3, vitamin A, vitamin B12, vitamin E and vitamin K were observed in patients who were monitor for 6 months.



No comments: